我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

血清可溶性P选择素和IL18水平与 冠状动脉病变程度相关研究(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2007年第4期
页码:
441-444/451
栏目:
临床研究
出版日期:
2007-08-01

文章信息/Info

Title:
Plasma concentration of serum soluble Pselection and interleukin18 in patients with acute coronary syndrome
作者:
唐园园;  龙明智;  陈磊磊
南京医科大学第二附属医院心内科，江苏 南京 210029
Author(s):
TANG Yuanyuan;  LONG Mingzhi;  CHEN Leilei
Department of Cardiology, Second Affiliated Hospital, Nanjing Medical University, NanJing 210029, Jiangsu, China
关键词:
P选择素; 白细胞介素18; 急性冠状动脉综合征
Keywords:
soluble Pselection ;  interleukin18;  acute coronary syndrome
分类号:
R541.4
DOI:
-
文献标识码:
A
摘要:
目的 探讨冠心病不同类型患者中血清可溶性P选择素、白细胞介素18(IL18)水平与疾病严重程度、冠状动脉粥样硬化狭窄程度是否相关。 方法 入选2006年5月至2006年11月冠心病患者包括急性冠脉综合征（ACS）和稳定型心绞痛（SAP）86例；用酶联免疫吸附法检测血清可溶性P选择素和IL18水平；对不稳定型心绞痛(UAP)患者进行Braunwald分级，对急性心肌梗死患者进行Killip分级，对冠状动脉粥样硬化病变程度按Gensini评分，用SPSS软件包进行统计学分析。 结果 ACS患者血清可溶性P选择素、IL18水平与疾病严重程度存在良好的相关性。ACS组P选择素和IL18水平高于SAP组，且与Gensini法评分呈线性正相关。 结论 ACS患者血清P选择素、IL18浓度与疾病的严重程度有一定的相关性, 与冠状动脉粥样硬化狭窄病变程度呈正相关。
Abstract:
AIM To elucidate whether the plasma concentrations of serum soluble Pselection and interleukin18 in different subtypes of coronary heart disease in patients with acute coronary syndrome (ACS) are correlated with the severity of the diseases and whether Pselection and IL18 are reliable biochemical markers indicating the severity of ACS. METHODS Enrolled in this study were 86 patients in Cardiology Department of the Hospital Affiliated to Nanjing Medical University from May 2006 to November 2006. The spectrum of ACS only included unstable angina pectoris (UAP) and acute myocardial infarction (AMI). The plasma concentrations of serum soluble Pselection and IL18 were measured by enzyme linked immunoabsorbent assay. The relationship between plasma soluble Pselection, IL18 levels and the coronary artery score (the severity of coronary heart disease) was assessed. Data were analyzed by SPSS. RESULTS The concentrations of serum soluble Pselection and IL18 in patients with ACS were dramatically correlative with the severity of the diseases. The levels of plasma soluble Pselection and IL18 were obviously higher in the acute coronary syndrome group than those in stable angina pectoris group. The two markers were positively correlated with the Gensini scores. CONCLUSION Plasma concentration of soluble Pselection and IL18 in patients with ACS can be used as reliable biochemical markers in assessing the degree of the disease. The positive correlation between the two markers and the coronary artery score may indicate that those levels might reflect the severity of coronary heart disease.

参考文献/References

［1］ Chamorro A.Role of inflammation in stroke and atherothrombosis［J］.Cerebrovasc Dis,2004,17 Suppl13:1-5.

［2］ Shebuski RJ, Kilgore KS. Role of inflammatory mediators in thrombogenesis［J］. J Pharmacol Exp Ther, 2002,300(3):729-735.

［3］ Carter AM, Anagnostopoulou K, Mansfield MW, et al. Soluble Pselectin levels, Pselectin polymorphisms and cardiovascular disease［J］.J Thromb Haemost,2003,1(8):1718-1723.

［4］Kato Y,Tsuda T,Hosaka Y,et al.Effect of trapidil on effector functions of monocytes related to atheroscleroticplaque［J］.Eur J Pharmacol,2001,428(3):371-379.

［5］Weyand CM,Goronzy JJ,Liuzzo G,et al.Tcell immunity in acute coronary syndromes［J］.Mayo Clin Proc,2001,76(10):1011-1020.

［6］ Laurat E, Poirier B, Tupin E, et al.In vivo downregulation of T helper cell. immune responses reduces atherogenesis in apolipoprotein Eknockout mice［J］.Circulation,2001,104(2):197-202.

［7］ Phillips JW, Barringhaus KG, Sanders JM, et al. Single injection of Pselectin or Pselectin glycoprotein ligand. monoclonal antibody blocks neointima formation after arterial injury in apolipoprotein Edeficient Mice［J］. Circulation,2003,107(17):2244-2249.

［8］ Hajilooi M,Sanati A,Ahmadieh A, et al.Circulating ICAM1,VCAM1,Eselectin,Pselectin and TNFalphaRⅡ in patients with coronary artery disease［J］.Immunol Invest,2003,32(4):245-257.

［9］ Mallat Z, Corbaz A, Scoazec A,et al. Expression of interleukin  18 in human atherosclerotic plaques and relation to plaque instability［J ］.Circulation,2001,104(14):1598-1603.

［10］Whitman SC, Ravisankar P, Daugherty A. Interleukin18 enhances atherosclerosisin apolipoproteinE(-/-) mice through release of interferon-gamma［J］. Circ Res,2002,90(2):E34-E38.

备注/Memo

备注/Memo:
收稿日期：2006-12-25.通讯作者：龙明智,主任医师，主要从事冠心病的诊断和治疗研究Email：longmzh@hotmail.com 作者简介：唐园园，硕士生Email：borubing@163.com
更新日期/Last Update: